Novolog 100 unit/ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FW8T4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,204
Award facts
- Contract value 100% obligated
- $3,204.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,204.22 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) under a firm fixed price contract. This is a non-set-aside award issued on August 25, 2025, with an ultimate completion date of August 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order for NovoLog insulin supports DLA's medical supply chain operations, which provide pharmaceutical and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's competitive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements, ranging from specialty medications to vaccines and medical devices across multiple therapeutic domains. The firm fixed price structure and rapid completion timeline reflect typical delivery order operations under the broader pharmaceutical prime vendor framework.
Quick answers
Who was awarded contract SPE2DB25FW8T4?
SPE2DB25FW8T4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FW8T4 worth?
The government has obligated $3,204 on SPE2DB25FW8T4.
Is contract SPE2DB25FW8T4 an order under another contract?
Yes. SPE2DB25FW8T4 is a delivery order under SPE2DB20D3304, an indefinite delivery contract.
Was contract SPE2DB25FW8T4 competed?
The extent of competition for SPE2DB25FW8T4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award